Literature DB >> 12616831

High-risk situations associated with parasuicide and drug use in borderline personality disorder.

Stacy Shaw Welch1, Marsha M Linehan.   

Abstract

Both parasuicide and drug use continue to be difficult problems to treat in borderline personality disorder (BPD). One useful approach that has not yet been applied to BPD is to develop a taxonomy of triggering situations for these problems. Once these high-risk precipitants are identified, then the behaviors can be targeted with skills training. This model has been applied by Marlatt (1996) with very influential results. To examine high-risk situations for parasuicide and drug use in BPD, the current study examined women with BPD who came to treatment for two different primary problems: parasuicide (N = 75) and drug dependence (N = 47). Participants identified the situation associated with highest risk for relapse in either the parasuicide or drug category. A taxonomy is presented, which divides results into six main categories. Differences between high-risk situations for drugs and parasuicide were also explored. Parasuicide was significantly more likely to be linked to interpersonal problems, whereas drug use was more likely to be preceded by addiction cues (i.e., being near drugs or people who use drugs).

Entities:  

Mesh:

Year:  2002        PMID: 12616831     DOI: 10.1521/pedi.16.6.561.22141

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  14 in total

Review 1.  Physical and social pains in borderline disorder and neuroanatomical correlates: a systematic review.

Authors:  Déborah Ducasse; Philippe Courtet; Emilie Olié
Journal:  Curr Psychiatry Rep       Date:  2014-05       Impact factor: 5.285

2.  Daily shame and hostile irritability in adolescent girls with borderline personality disorder symptoms.

Authors:  Lori N Scott; Stephanie D Stepp; Michael N Hallquist; Diana J Whalen; Aidan G C Wright; Paul A Pilkonis
Journal:  Personal Disord       Date:  2015-01

3.  Suicidal Ideation Among Drug-Dependent Treatment-Seeking Inner-City Pregnant Women.

Authors:  Marc L Copersino; Hendrée Jones; Michelle Tuten; Dace Svikis
Journal:  J Maint Addict       Date:  2008-01-01

4.  An exploratory study of the relationship between diverse life events and specific personality disorders in a sample of suicide attempters.

Authors:  Hilario Blasco-Fontecilla; Enrique Baca-Garcia; Paul Duberstein; M Mercedes Perez-Rodriguez; Kanita Dervic; Jeronimo Saiz-Ruiz; Philippe Courtet; Jose de Leon; Maria A Oquendo
Journal:  J Pers Disord       Date:  2010-12

5.  The rejection-rage contingency in borderline personality disorder.

Authors:  Kathy R Berenson; Geraldine Downey; Eshkol Rafaeli; Karin G Coifman; Nina Leventhal Paquin
Journal:  J Abnorm Psychol       Date:  2011-08

Review 6.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

7.  Impulsivity, Rejection Sensitivity, and Reactions to Stressors in Borderline Personality Disorder.

Authors:  Kathy R Berenson; Wesley Ellen Gregory; Erin Glaser; Aliza Romirowsky; Eshkol Rafaeli; Xiao Yang; Geraldine Downey
Journal:  Cognit Ther Res       Date:  2016-01-20

8.  The role of attachment styles and interpersonal problems in suicide-related behaviors.

Authors:  Stephanie D Stepp; Jennifer Q Morse; Kirsten E Yaggi; Sarah K Reynolds; L Ian Reed; Paul A Pilkonis
Journal:  Suicide Life Threat Behav       Date:  2008-10

9.  The role of interpersonal conflict and perceived social support in nonsuicidal self-injury in daily life.

Authors:  Brianna J Turner; Rebecca J Cobb; Kim L Gratz; Alexander L Chapman
Journal:  J Abnorm Psychol       Date:  2016-02-04

10.  Association between 5-HTTLPR and Borderline Personality Disorder Traits among Youth.

Authors:  Benjamin L Hankin; Andrea L Barrocas; Jessica Jenness; Caroline W Oppenheimer; Lisa S Badanes; John R Z Abela; Jami Young; Andrew Smolen
Journal:  Front Psychiatry       Date:  2011-03-01       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.